BioSpace News Archive

Policy

bluebird bio Announces Live Webcast of EHA Data Review and ZYNTEGLO® (autologous CD34+ cells encoding βA-T87Q-globin gene) Approval

bluebird bio, Inc. announced that the company will host a live webcast to review new data presented at the European Hematology Association Annual Meeting, and to discuss the approval of ZYNTEGLO® on Friday, June 14 at 8:00 a.m. ET.

June 6, 2019
·
3 min read
BioMidwest

Summertime -- And the Scheduling is Easy at Fraser

During the school year, life is hectic for many Minnesota families.

June 6, 2019
·
2 min read
Deals

Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics

Vertex Pharmaceuticals Incorporated announced that the company is enhancing its gene editing capabilities to develop novel therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1 by expanding its collaboration with CRISPR Therapeutics and acquiring Exonics Therapeutics.

June 6, 2019
·
13 min read
Business

DionyMed Brands Inc. Announces Investment Agreement for up to CAD$32 Million with Alumina Partners

DionyMed Brands Inc. announced that it has entered into an investment agreement with Alumina Partners Ltd. providing availability of up to CAD$32 million over a 24-month period, to provide funding for the expansion of the Company’s leading cannabis product portfolio into new growth markets.

June 6, 2019
·
6 min read
BioForest

New Intuitive Rheometer Series Designed for Quality Control Labs

Thermo Scientific HAAKE MARS iQ Rheometer series provides more analytical capabilities for QC and reliable, user-independent results

June 6, 2019
·
2 min read
Deals

Nonprofit CureDuchenne is Encouraged to See Gene Editing for Duchenne Advance Through Vertex’s Acquisition of Exonics Therapeutics

Deal will accelerate drug development for Duchenne muscular dystrophy, a rare disease that affects 300,000 boys and young men worldwide

June 6, 2019
·
3 min read
Genetown

Harvard Business School Announces $10 Million Gift Renewal from the Blavatnik Family Foundation and Introduces 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship

Harvard Business School (HBS) has named its 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship.

June 6, 2019
·
6 min read
BioCapital

Congressman Mark Meadows Discusses End to Fetal Tissue Research Contracts on Washington Watch with Tony Perkins

Yesterday, House Freedom Caucus Chairman Mark Meadows (R-N.C) appeared on Washington Watch with Tony Perkins to discuss the decision by the Department of Health and Human Services (HHS) to end research contracts using fetal tissue through the National Institutes of Health (NIH)

June 6, 2019
·
2 min read
Drug Development

Purdue Pharma Announces First Participant Enrolled in Clinical Study Assessing Nalmefene HCl Injection for the Emergency Treatment of Known or Suspected Opioid Overdose

Purdue Pharma L.P. today announced the initiation and first participant enrollment in a Phase 1 clinical study that will examine pharmacokinetic properties of nalmefene hydrochloride (HCl).

June 6, 2019
·
5 min read
Pharm Country

The American Cancer Society to Host its Annual Financial Services Cares Gala

The Financial Services Cares Gala (FSCG) will celebrate its 14th year on Thursday, June 13, 2019, at the New York Hilton Midtown

June 6, 2019
·
3 min read